PKL-IN-1
PKL-IN-1 is a potent inhibitor of pyruvate kinase (PKL) with an IC50 of 0.07 μM. PKL-IN-1 can be used in the study of non-alcoholic fatty liver disease[1].
Product Specifications
UNSPSC
12352005
Target
Pyruvate Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pkl-in-1.html
Purity
99.36
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC1=C(O)C=C(C(C(O)=C(O)C(O)=C2)=C2OS3(=O)=O)C3=C1
Molecular Formula
C12H8O8S
Molecular Weight
312.25
References & Citations
[1]Matić J, et al. Sulfone-based human liver pyruvate kinase inhibitors - Design, synthesis and in vitro bioactivity. Eur J Med Chem. 2024;269:116306.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161337/PKL-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161337/PKL-IN-1-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Mitochondrial Translation Release Factor in Rescue (MTRFR) Antibody (HRP)
Mitochondrial Translation Release Factor in Rescue (MTRFR) Antibody (HRP)
Mitochondrial Translation Release Factor in Rescue (MTRFR) Antibody (HRP)
Mitochondrial Translation Release Factor in Rescue (MTRFR) Antibody (HRP)
